U.S., Nov. 25 -- ClinicalTrials.gov registry received information related to the study (NCT07245147) titled 'REDO-AF: Randomized Evaluation of Dual Options for AF Re-intervention' on Nov. 17.
Brief Summary: The goal of this randomized open-label clinical trial is to evaluate two different strategies for the treatment of recurrent atrial fibrillation (AF) after AF ablation. Patients who have symptomatic, drug-refractory recurrence of AF will be randomized to either a redo AF ablation vs conduction system pacing with AV node ablation. Patients will need to have undergone at least 1 prior AF ablation to be considered eligible for the study. The current trial is a vanguard study of 16 patients and will determine the feasibility of enrolment, c...